Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026
Same author

Super-Resolution Ultrasound Based Cell Tracking With Polymeric Nanobubbles.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics.

Chemical Society reviews·2026
Same author

Validation of an automated AI-based micro-CT organ segmentation workflow against expert annotations and its impact on fluorescence quantification.

European radiology experimental·2026
Same author

Future Challenges of Molecular Imaging in Oncology.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same author

Molecular Ultrasound Imaging.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

Related Experiment Video

Updated: Jun 2, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Theranostic nanomedicine.

Twan Lammers1, Silvio Aime, Wim E Hennink

  • 1Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. tlammers@ukaachen.de

Accounts of Chemical Research
|May 7, 2011
PubMed
Summary
This summary is machine-generated.

Theranostic nanomedicines combine therapy and diagnostics for improved drug delivery and personalized medicine. These systems monitor drug distribution and efficacy, optimizing treatments and reducing toxicity.

More Related Videos

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Related Experiment Videos

Last Updated: Jun 2, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Area of Science:

  • Nanomedicine
  • Theranostics
  • Personalized Medicine

Background:

  • Nanomedicine formulations enhance drug delivery and target site accumulation.
  • Various nanocarriers (liposomes, polymers, micelles, antibodies) improve therapeutic efficacy and reduce toxicity.
  • Nanomedicines are increasingly used for imaging and combined diagnostic/therapeutic (theranostic) applications.

Purpose of the Study:

  • To summarize exemplary efforts in theranostic nanomedicine.
  • To demonstrate the suitability of theranostic nanomedicines for monitoring drug delivery, release, and efficacy.
  • To highlight applications in optimizing drug delivery systems and enabling personalized medicine.

Main Methods:

  • Development of theranostic nanomedicines integrating diagnostic and therapeutic agents.
  • Utilizing theranostic systems for real-time feedback on pharmacokinetics and biodistribution.
  • Non-invasive visualization of nanomedicine delivery to pathological sites and healthy organs.

Main Results:

  • Theranostic nanomedicines provide real-time monitoring of drug delivery and accumulation.
  • Visualization aids in optimizing nanocarrier properties and balancing therapeutic efficacy with toxicity.
  • Theranostic systems enable patient pre-screening and personalized treatment strategies.

Conclusions:

  • Theranostic nanomedicines are crucial for validating and optimizing drug delivery systems.
  • These systems facilitate personalized medicine by identifying suitable candidates for targeted therapy.
  • Further development of theranostic nanomedicines is expected to significantly advance personalized medicine.